Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: week 52 results from SPIRIT-P2
Genovese, Mark C, Combe, Benard, Kremer, Joel M, Tsai, Tsen-Fang, Behrens, Frank, Adams, David H, Lee, Chin, Kerr, Lisa, Nash, PeterLangue:
english
Journal:
Rheumatology
DOI:
10.1093/rheumatology/key182
Date:
July, 2018
Fichier:
PDF, 612 KB
english, 2018